Telatinib (Compound)

Synonyms:Telatinib, 332012-40-5, Bay 57-9352, Telatinib (BAY 57-9352), Telatinib [INN], BAY-579352, 4-[[4-(4-chloroanilino)furo[2,3-d]pyridazin-7-yl]oxymethyl]-N-methylpyridine-2-carboxamide, 4-[[4-(4-Chloroanilino)furo[2,3-d]pyridazin-7-yl]oxymethyl]-N-methyl-pyridine-2-carboxamide, BAY57-9352, BAY-57-9352, CHEMBL2079588, 18P7197Q7J, 4-(((4-((4-chlorophenyl)amino)furo[2,3-d]pyridazin-7-yl)oxy)methyl)-N-methylpicolinamide, 4-((4-(4-chlorophenylamino)furo[2,3-d]pyridazin-7-yloxy)methyl)-N-methylpicolinamide, UNII-18P7197Q7J, TELATINIB [WHO-DD], MLS006010950, SCHEMBL1250560, Bay 57-9352 (Telatinib), GTPL10476, Telatinib - BAY 57-9352, DTXSID70954809, EX-A007, BCPP000050, HMS3655F14, BCP02409, BAY579352, BDBM50399538, MFCD18251453, NSC776017, NSC800944, s2231, AKOS015909525, BAY 579352, CCG-264951, CS-3722, DB15393, EX-8672, NSC-776017, NSC-800944, PB30302, SB13250, NCGC00249392-01, NCGC00249392-05, 2-Pyridinecarboxamide, 4-(((4-((4-chlorophenyl)amino)furo(2,3-d)pyridazin-7-yl)oxy)methyl)-N-methyl-, AC-25239, example 14 [WO2001023375A2], HY-10527, MS-27057, SMR004702754, FT-0674832, SW220176-1, A25614, J-524317, Q27252023, 4-(((4-((4-CHLOROPHENYL)AMINO)FURO(2,3-D)PYRIDAZIN-7-YL)OXY)METHYL)-N-METHYLPYRIDINE-2-CARBOXAMIDE, 4-({[4-(4-Chloroanilino)furo[2,3-d]pyridazin-7-yl]oxy}methyl)-N-methylpyridine-2-carboxamide

Pubchem:PUBCHEM:9808844

Id:3ad69e32-c40b-5975-8b48-7db614e1c220

Description:nan